AQSTAquestive Therapeutics, Inc.
- Market cap
- $502.05M
- as of 2026-10-23
- Latest close
- $4.00
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Drug Manufacturers - Specialty & Generic
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-03-11
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Cochran John | Oct 21 | Oct 23 | J | 62,229 | $0.00 | $0 | 161,715 | No | Form 4 |
| Barber DanielPresident and CEO | Oct 15 | Oct 16 | S | 25,000 | $4.22 | Sale −$105,600 | 627,317 | Yes | Form 4 |
| Barber DanielPresident and CEO | Sep 15 | Sep 16 | S | 25,000 | $4.82 | Sale −$120,500 | 652,317 | Yes | Form 4 |
| Korczynski SherryChief Commercial Officer | Sep 9 | Sep 11 | M | 8,750 | $2.65 | $23,188 | 244,439 | Yes | Form 4 |
| Korczynski SherryChief Commercial Officer | Sep 9 | Sep 11 | S | 8,750 | $5.22 | Sale −$45,675 | 235,689 | Yes | Form 4 |
| Korczynski SherryChief Commercial Officer | Sep 9 | Sep 11 | M · derivative | 8,750 | $2.65 | $23,188 | 26,250 | Yes | Form 4 |
| Boyd Peter E.Chief People Officer | Sep 9 | Sep 10 | X | 2,293 | $0.96 | $2,201 | 284,024 | No | Form 4 |
| Boyd Peter E.Chief People Officer | Sep 9 | Sep 10 | X · derivative | 2,293 | $0.96 | $2,201 | not reported | No | Form 4 |
| Barber DanielPresident and CEO | Sep 8 | Sep 9 | X | 91,743 | $0.96 | $88,073 | 677,317 | No | Form 4 |
| Barber DanielPresident and CEO | Sep 8 | Sep 9 | X · derivative | 91,743 | $0.96 | $88,073 | not reported | No | Form 4 |
| Jung CassieChief Operating Officer | Sep 3 | Sep 8 | X | 4,587 | $0.96 | $4,404 | 206,833 | No | Form 4 |
| Jung CassieChief Operating Officer | Sep 3 | Sep 8 | X · derivative | 4,587 | $0.96 | $4,404 | not reported | No | Form 4 |
| Barber DanielPresident and CEO | Aug 17 | Aug 18 | S | 25,000 | $4.29 | Sale −$107,250 | 585,574 | Yes | Form 4 |
| Korczynski SherryChief Commercial Officer | Aug 14 | Aug 17 | F | 2,714 | $4.25 | $11,535 | 235,689 | No | Form 4 |
| Barber DanielPresident and CEO | Jul 16 | Jul 17 | S | 20,369 | $4.00 | Sale −$81,476 | 610,574 | Yes | Form 4 |
| Barber DanielPresident and CEO | Jul 15 | Jul 17 | S | 4,631 | $4.03 | Sale −$18,663 | 630,943 | Yes | Form 4 |
| Krop Julie | Jun 23 | Jun 24 | M | 25,000 | $0.71 | $17,750 | 25,000 | Yes | Form 4 |
| Krop Julie | Jun 23 | Jun 24 | S | 25,000 | $5.02 | Sale −$125,500 | not reported | Yes | Form 4 |
| Krop Julie | Jun 23 | Jun 24 | M · derivative | 25,000 | $0.71 | $17,750 | not reported | Yes | Form 4 |
| Barber DanielPresident and CEO | Jun 15 | Jun 16 | S | 25,000 | $4.16 | Sale −$104,000 | 635,574 | Yes | Form 4 |
| Taglietti Marco | Jun 10 | Jun 12 | A · derivative | 50,500 | $3.99 | $201,495 | 50,500 | No | Form 4 |
| Brown Gregory B | Jun 10 | Jun 12 | A · derivative | 50,500 | $3.99 | $201,495 | 50,500 | No | Form 4 |
| Cochran John | Jun 10 | Jun 12 | A · derivative | 50,500 | $3.99 | $201,495 | 50,500 | No | Form 4 |
| Jenkins Abigail L. | Jun 10 | Jun 12 | A · derivative | 50,500 | $3.99 | $201,495 | 50,500 | No | Form 4 |
| Krop Julie | Jun 10 | Jun 12 | A · derivative | 50,500 | $3.99 | $201,495 | 50,500 | No | Form 4 |
| Morris Timothy E | Jun 10 | Jun 12 | A · derivative | 50,500 | $3.99 | $201,495 | 50,500 | No | Form 4 |
| Korczynski SherryChief Commercial Officer | Jun 8 | Jun 9 | F | 2,714 | $0.00 | $0 | 238,403 | No | Form 4 |
| Zalewski Thomas A.Chief Legal Officer | May 18 | May 19 | A | 100,000 | $0.00 | $0 | 100,000 | No | Form 4 |
| Zalewski Thomas A.Chief Legal Officer | May 18 | May 19 | A · derivative | 75,000 | $4.14 | $310,500 | 75,000 | No | Form 4 |
| Cioffi MelinaSVP, Regulatory Affairs | May 15 | May 18 | F | 1,667 | $4.17 | $6,951 | 273,200 | No | Form 4 |
| Barber DanielPresident and CEO | May 15 | May 18 | S | 8,257 | $4.29 | Sale −$35,423 | 660,574 | Yes | Form 4 |
| Braender Lori JCorporate Secretary | May 7 | May 11 | F | 135,690 | $4.23 | $573,969 | 231,042 | No | Form 4 |
| Braender Lori JCorporate Secretary | May 5 | May 7 | F | 76,147 | $4.18 | $318,294 | 366,732 | No | Form 4 |
| Jung CassieChief Operating Officer | May 5 | May 7 | F | 72,734 | $4.18 | $304,028 | 202,246 | No | Form 4 |
| Toth A Ernest JrChief Financial Officer | May 5 | May 7 | F | 92,652 | $4.18 | $387,285 | 283,460 | No | Form 4 |
| Barber DanielPresident and CEO | May 5 | May 7 | F | 335,922 | $4.18 | $1,404,154 | 668,831 | No | Form 4 |
| Boyd Peter E.Chief People Officer | May 5 | May 7 | F | 56,778 | $4.18 | $237,332 | 281,731 | No | Form 4 |
| Braender Lori JCorporate Secretary | Mar 7, 2025 | Apr 13 | A · derivative | 82,500 | $0.00 | $0 | 82,500 | No | Form 4 |
| Korczynski SherryChief Commercial Officer | Mar 7, 2025 | Apr 13 | A · derivative | 67,500 | $0.00 | $0 | 67,500 | No | Form 4 |
| Toth A Ernest JrSVP, Chief Financial Officer | Mar 7, 2025 | Apr 13 | A · derivative | 82,500 | $0.00 | $0 | 82,500 | No | Form 4 |
| Jung CassieChief Operating Officer | Mar 7, 2025 | Apr 13 | A · derivative | 60,000 | $0.00 | $0 | 60,000 | No | Form 4 |
| Boyd Peter E.Chief People Officer | Mar 7, 2025 | Apr 13 | A · derivative | 60,000 | $0.00 | $0 | 60,000 | No | Form 4 |
| Barber DanielPresident and CEO | Mar 7, 2025 | Apr 13 | A · derivative | 293,100 | $0.00 | $0 | 293,100 | No | Form 4 |
| Jung CassieChief Operating Officer | Mar 10 | Mar 11 | S | 45,791 | $4.17 | Sale −$190,948 | 274,980 | No | Form 4 |
| Korczynski SherryChief Commercial Officer | Mar 10 | Mar 11 | S | 15,741 | $4.17 | Sale −$65,640 | 241,117 | No | Form 4 |
| Toth A Ernest JrChief Financial Officer | Mar 10 | Mar 11 | S | 58,254 | $4.17 | Sale −$242,919 | 376,112 | No | Form 4 |
| Cioffi MelinaSVP, Regulatory Affairs | Mar 10 | Mar 11 | S | 25,311 | $4.17 | Sale −$105,547 | 274,867 | No | Form 4 |
| Braender Lori JChief Legal Officer | Mar 10 | Mar 11 | S | 40,102 | $4.17 | Sale −$167,225 | 442,879 | No | Form 4 |
| Barber DanielPresident and CEO | Mar 10 | Mar 11 | S | 180,677 | $4.17 | Sale −$753,423 | 1,004,753 | No | Form 4 |
| Boyd Peter E.Chief People Officer | Mar 10 | Mar 11 | S | 29,814 | $4.17 | Sale −$124,324 | 338,509 | No | Form 4 |
| Greenhawt Matthew J.Chief Medical Officer | Mar 9 | Mar 11 | A | 75,000 | $0.00 | $0 | 75,000 | No | Form 4 |
| Greenhawt Matthew J.Chief Medical Officer | Mar 9 | Mar 11 | A · derivative | 50,000 | $4.29 | $214,500 | 50,000 | No | Form 4 |
| Davis Matthew W.Chief Development Officer | Mar 9 | Mar 11 | A | 50,000 | $0.00 | $0 | 100,000 | No | Form 4 |
| Davis Matthew W.Chief Development Officer | Mar 9 | Mar 11 | A · derivative | 50,000 | $4.29 | $214,500 | 50,000 | No | Form 4 |
| Jung CassieChief Operating Officer | Mar 9 | Mar 11 | A | 80,000 | $0.00 | $0 | 320,771 | No | Form 4 |
| Jung CassieChief Operating Officer | Mar 9 | Mar 11 | A · derivative | 42,500 | $4.29 | $182,325 | 42,500 | No | Form 4 |
| Korczynski SherryChief Commercial Officer | Mar 9 | Mar 11 | A | 75,000 | $0.00 | $0 | 256,858 | No | Form 4 |
| Korczynski SherryChief Commercial Officer | Mar 9 | Mar 11 | A · derivative | 42,500 | $4.29 | $182,325 | 42,500 | No | Form 4 |
| Toth A Ernest JrChief Financial Officer | Mar 9 | Mar 11 | A | 95,000 | $0.00 | $0 | 434,366 | No | Form 4 |
| Toth A Ernest JrChief Financial Officer | Mar 9 | Mar 11 | A · derivative | 70,000 | $4.29 | $300,300 | 70,000 | No | Form 4 |
| Cioffi MelinaSVP, Regulatory Affairs | Mar 9 | Mar 11 | A | 100,000 | $0.00 | $0 | 300,178 | No | Form 4 |
| Cioffi MelinaSVP, Regulatory Affairs | Mar 9 | Mar 11 | A · derivative | 75,000 | $4.29 | $321,750 | 75,000 | No | Form 4 |
| Braender Lori JChief Legal Officer | Mar 9 | Mar 11 | A | 80,000 | $0.00 | $0 | 482,981 | No | Form 4 |
| Braender Lori JChief Legal Officer | Mar 9 | Mar 11 | A · derivative | 50,000 | $4.29 | $214,500 | 50,000 | No | Form 4 |
| Barber DanielPresident and CEO | Mar 9 | Mar 11 | A | 262,000 | $0.00 | $0 | 1,185,430 | No | Form 4 |
| Barber DanielPresident and CEO | Mar 9 | Mar 11 | A · derivative | 523,000 | $4.29 | $2,243,670 | 523,000 | No | Form 4 |
| Boyd Peter E.Chief People Officer | Mar 9 | Mar 11 | A | 80,000 | $0.00 | $0 | 368,323 | No | Form 4 |
| Boyd Peter E.Chief People Officer | Mar 9 | Mar 11 | A · derivative | 42,500 | $4.29 | $182,325 | 42,500 | No | Form 4 |
| Boyd Peter E.Chief People Officer | Dec 4, 2025 | Dec 5, 2025 | A | 20,000 | $0.00 | $0 | 288,323 | No | Form 4 |
| Cioffi MelinaSVP, Regulatory Affairs | Dec 2, 2025 | Dec 4, 2025 | F | 2,083 | $5.93 | $12,352 | 200,178 | No | Form 4 |
| Davis Matthew W.Chief Development Officer | Nov 10, 2025 | Nov 12, 2025 | A | 50,000 | $0.00 | $0 | 50,000 | No | Form 4 |
| Davis Matthew W.Chief Development Officer | Nov 10, 2025 | Nov 12, 2025 | A · derivative | 50,000 | $5.58 | $279,000 | 50,000 | No | Form 4 |
| Boyd Peter E.See Remarks | Oct 15, 2025 | Oct 17, 2025 | S | 10,000 | $7.00 | Sale −$70,000 | 268,323 | Yes | Form 4 |
| Kraus Carl NChief Medical Officer | Oct 15, 2025 | Oct 17, 2025 | S | 20,272 | $7.00 | Sale −$141,904 | 282,475 | Yes | Form 4 |
| Jung CassieChief Operating Officer | Oct 15, 2025 | Oct 17, 2025 | M | 25,000 | $3.10 | $77,500 | 308,346 | Yes | Form 4 |
| Jung CassieChief Operating Officer | Oct 15, 2025 | Oct 17, 2025 | S | 67,575 | $7.01 | Sale −$473,701 | 240,771 | Yes | Form 4 |
| Jung CassieChief Operating Officer | Oct 15, 2025 | Oct 17, 2025 | M · derivative | 25,000 | $3.10 | $77,500 | not reported | Yes | Form 4 |
| Boyd Peter E.See Remarks | Sep 26, 2025 | Sep 29, 2025 | S | 10,000 | $6.30 | Sale −$63,000 | 278,323 | Yes | Form 4 |
| Barber DanielPresident and CEO | Sep 26, 2025 | Sep 29, 2025 | S | 91,343 | $6.03 | Sale −$550,798 | 923,430 | Yes | Form 4 |
| Barber DanielPresident and CEO | Sep 19, 2025 | Sep 22, 2025 | S | 400 | $6.00 | Sale −$2,400 | 1,014,773 | Yes | Form 4 |
| Boyd Peter E.See Remarks | Sep 5, 2025 | Sep 8, 2025 | S | 15,000 | $5.30 | Sale −$79,500 | 288,323 | Yes | Form 4 |
| Jung CassieChief Operating Officer | Sep 4, 2025 | Sep 8, 2025 | M | 25,000 | $3.15 | $78,750 | 320,526 | Yes | Form 4 |
| Jung CassieChief Operating Officer | Sep 4, 2025 | Sep 8, 2025 | M | 25,000 | $0.71 | $17,750 | 345,526 | Yes | Form 4 |
| Jung CassieChief Operating Officer | Sep 4, 2025 | Sep 8, 2025 | S | 62,180 | $5.00 | Sale −$310,900 | 283,346 | Yes | Form 4 |
| Jung CassieChief Operating Officer | Sep 4, 2025 | Sep 8, 2025 | M · derivative | 25,000 | $3.15 | $78,750 | not reported | Yes | Form 4 |
| Jung CassieChief Operating Officer | Sep 4, 2025 | Sep 8, 2025 | M · derivative | 25,000 | $0.71 | $17,750 | not reported | Yes | Form 4 |
| Korczynski SherryChief Commercial Officer | Aug 14, 2025 | Aug 15, 2025 | A | 25,000 | $0.00 | $0 | 181,858 | No | Form 4 |
| Kraus Carl NChief Medical Officer | Aug 9, 2025 | Aug 12, 2025 | F | 10,819 | $3.90 | $42,194 | 302,747 | No | Form 4 |
| Taglietti Marco | Jun 11, 2025 | Jun 12, 2025 | A · derivative | 42,000 | $3.41 | $143,220 | 42,000 | No | Form 4 |
| Cochran John | Jun 11, 2025 | Jun 12, 2025 | A · derivative | 42,000 | $3.41 | $143,220 | 42,000 | No | Form 4 |
| Jenkins Abigail L. | Jun 11, 2025 | Jun 12, 2025 | A · derivative | 42,000 | $3.41 | $143,220 | 42,000 | No | Form 4 |
| Morris Timothy E | Jun 11, 2025 | Jun 12, 2025 | A · derivative | 42,000 | $3.41 | $143,220 | 42,000 | No | Form 4 |
| Krop Julie | Jun 11, 2025 | Jun 12, 2025 | A · derivative | 42,000 | $3.41 | $143,220 | 42,000 | No | Form 4 |
| Brown Gregory B | Jun 11, 2025 | Jun 12, 2025 | A · derivative | 42,000 | $3.41 | $143,220 | 42,000 | No | Form 4 |
| Korczynski SherrySVP Sales and Marketing | Jun 9, 2025 | Jun 10, 2025 | F | 2,714 | $3.54 | $9,608 | 156,858 | No | Form 4 |
| Cioffi MelinaSVP, Regulatory Affairs | May 15, 2025 | May 15, 2025 | A | 20,000 | $0.00 | $0 | 202,261 | No | Form 4 |
| Jung CassieChief Operating Officer | Mar 10, 2025 | Mar 11, 2025 | F | 2,182 | $2.54 | $5,542 | 295,526 | No | Form 4 |
| Wargacki StephenChief Science Officer | Mar 10, 2025 | Mar 11, 2025 | F | 4,572 | $2.54 | $11,613 | 343,552 | No | Form 4 |
| Barber DanielPresident and CEO | Mar 9, 2025 | Mar 11, 2025 | F | 53,998 | $2.65 | $143,095 | 1,015,173 | No | Form 4 |
| Boyd Peter E.See Remark | Mar 9, 2025 | Mar 11, 2025 | F | 7,681 | $2.65 | $20,355 | 303,323 | No | Form 4 |
| Braender Lori JChief Legal Officer | Mar 9, 2025 | Mar 11, 2025 | F | 10,658 | $2.65 | $28,244 | 402,981 | No | Form 4 |
| Toth A Ernest JrChief Financial Officer | Mar 9, 2025 | Mar 11, 2025 | F | 8,736 | $2.65 | $23,150 | 339,366 | No | Form 4 |
| Jung CassieChief Operating Officer | Mar 9, 2025 | Mar 11, 2025 | F | 7,997 | $2.65 | $21,192 | 297,708 | No | Form 4 |
| Wargacki StephenChief Science Officer | Mar 9, 2025 | Mar 11, 2025 | F | 15,431 | $2.65 | $40,892 | 348,124 | No | Form 4 |
| Barber DanielPresident and CEO | Mar 7, 2025 | Mar 11, 2025 | A | 272,000 | $0.00 | $0 | 1,098,478 | No | Form 4 |
| Barber DanielPresident and CEO | Mar 7, 2025 | Mar 11, 2025 | F | 29,307 | $2.65 | $77,664 | 1,069,171 | No | Form 4 |
| Barber DanielPresident and CEO | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 408,000 | $2.65 | $1,081,200 | 408,000 | No | Form 4 |
| Boyd Peter E.See Remark | Mar 7, 2025 | Mar 11, 2025 | A | 80,000 | $0.00 | $0 | 317,628 | No | Form 4 |
| Boyd Peter E.See Remark | Mar 7, 2025 | Mar 11, 2025 | F | 6,624 | $2.65 | $17,554 | 311,004 | No | Form 4 |
| Boyd Peter E.See Remark | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 40,000 | $2.65 | $106,000 | 40,000 | No | Form 4 |
| Braender Lori JChief Legal Officer | Mar 7, 2025 | Mar 11, 2025 | A | 110,000 | $0.00 | $0 | 423,231 | No | Form 4 |
| Braender Lori JChief Legal Officer | Mar 7, 2025 | Mar 11, 2025 | F | 9,592 | $2.65 | $25,419 | 413,639 | No | Form 4 |
| Braender Lori JChief Legal Officer | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 60,000 | $2.65 | $159,000 | 60,000 | No | Form 4 |
| Korczynski SherrySVP Sales and Marketing | Mar 7, 2025 | Mar 11, 2025 | A | 90,000 | $0.00 | $0 | 165,000 | No | Form 4 |
| Korczynski SherrySVP Sales and Marketing | Mar 7, 2025 | Mar 11, 2025 | F | 5,428 | $2.65 | $14,384 | 159,572 | No | Form 4 |
| Korczynski SherrySVP Sales and Marketing | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 35,000 | $2.65 | $92,750 | 35,000 | No | Form 4 |
| Kraus Carl NChief Medical Officer | Mar 7, 2025 | Mar 11, 2025 | A | 70,000 | $0.00 | $0 | 321,681 | No | Form 4 |
| Kraus Carl NChief Medical Officer | Mar 7, 2025 | Mar 11, 2025 | F | 8,115 | $2.65 | $21,505 | 313,566 | No | Form 4 |
| Kraus Carl NChief Medical Officer | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 30,000 | $2.65 | $79,500 | 30,000 | No | Form 4 |
| Toth A Ernest JrChief Financial Officer | Mar 7, 2025 | Mar 11, 2025 | A | 110,000 | $0.00 | $0 | 358,295 | No | Form 4 |
| Toth A Ernest JrChief Financial Officer | Mar 7, 2025 | Mar 11, 2025 | F | 10,193 | $2.65 | $27,011 | 348,102 | No | Form 4 |
| Toth A Ernest JrChief Financial Officer | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 60,000 | $2.65 | $159,000 | 60,000 | No | Form 4 |
| Jung CassieChief Operating Officer | Mar 7, 2025 | Mar 11, 2025 | A | 80,000 | $0.00 | $0 | 313,066 | No | Form 4 |
| Jung CassieChief Operating Officer | Mar 7, 2025 | Mar 11, 2025 | F | 7,361 | $2.65 | $19,507 | 305,705 | No | Form 4 |
| Jung CassieChief Operating Officer | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 40,000 | $2.65 | $106,000 | 40,000 | No | Form 4 |
| Wargacki StephenChief Science Officer | Mar 7, 2025 | Mar 11, 2025 | A | 115,000 | $0.00 | $0 | 376,414 | No | Form 4 |
| Wargacki StephenChief Science Officer | Mar 7, 2025 | Mar 11, 2025 | F | 12,859 | $2.65 | $34,076 | 363,555 | No | Form 4 |
| Wargacki StephenChief Science Officer | Mar 7, 2025 | Mar 11, 2025 | A · derivative | 65,000 | $2.65 | $172,250 | 65,000 | No | Form 4 |
| Bratton Douglas K | Dec 2, 2024 | Dec 4, 2024 | G | 40,000 | $0.00 | $0 | 199,841 | No | Form 4 |
| Jung CassieChief Operating Officer | Nov 26, 2024 | Nov 27, 2024 | S | 44 | $4.87 | Sale −$214 | not reported | No | Form 4 |
| Jung CassieSVP, Operations | Mar 9, 2024 | Oct 2, 20244/A | F | 14,120 | $4.88 | $68,906 | 233,066 | No | Form 4/A |
| Barber DanielPresident and CEO | Mar 9, 2024 | Oct 2, 20244/A | F | 56,824 | $4.88 | $277,301 | 826,478 | No | Form 4/A |
| Wargacki StephenChief Science Officer | Mar 9, 2024 | Oct 2, 20244/A | F | 19,505 | $4.88 | $95,184 | 261,414 | No | Form 4/A |
| Schobel Alexander MarkChief Innovation/Tech Officer | Mar 9, 2024 | Oct 2, 20244/A | F | 9,645 | $4.88 | $47,068 | 980,726 | No | Form 4/A |
| Kraus Carl NChief Medical Officer | Aug 9, 2024 | Aug 12, 2024 | F | 10,819 | $3.43 | $37,109 | 251,681 | No | Form 4 |
| Costa Santo J | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 38,000 | $2.50 | $95,000 | 38,000 | No | Form 4 |
| Cochran John | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 38,000 | $2.50 | $95,000 | 38,000 | No | Form 4 |
| Krop Julie | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 38,000 | $2.50 | $95,000 | 38,000 | No | Form 4 |
| Brown Gregory B | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 38,000 | $2.50 | $95,000 | 38,000 | No | Form 4 |
| Taglietti Marco | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 38,000 | $2.50 | $95,000 | 38,000 | No | Form 4 |
| Morris Timothy E | Jun 20, 2024 | Jun 21, 2024 | A · derivative | 38,000 | $2.50 | $95,000 | 38,000 | No | Form 4 |
| Korczynski SherrySVP Sales and Marketing | Jun 7, 2024 | Jun 11, 2024 | A | 25,000 | $0.00 | $0 | 25,000 | No | Form 4 |
| Jenkins Abigail L. | May 10, 2024 | May 13, 2024 | A · derivative | 57,000 | $3.09 | $176,130 | 57,000 | No | Form 4 |
| Wargacki StephenChief Science Officer | May 10, 2024 | May 13, 2024 | A | 10,000 | $0.00 | $0 | 267,963 | No | Form 4 |
| Schobel Alexander MarkChief Innovation/Tech Officer | Mar 15, 2024 | Mar 19, 2024 | S | 50,000 | $6.00 | Sale −$300,000 | 984,476 | Yes | Form 4 |
| Schobel Alexander MarkChief Innovation/Tech Officer | Mar 9, 2024 | Mar 12, 2024 | F | 5,895 | $4.88 | $28,768 | 1,034,476 | Yes | Form 4 |
| Toth A Ernest JrSVP, Chief Financial Officer | Mar 9, 2024 | Mar 12, 2024 | F | 11,705 | $4.88 | $57,120 | 248,295 | No | Form 4 |
| Braender Lori JSVP, General Counsel | Mar 9, 2024 | Mar 12, 2024 | F | 10,530 | $4.88 | $51,386 | 313,231 | No | Form 4 |
| Boyd Peter E.See Remark | Mar 9, 2024 | Mar 12, 2024 | F | 8,370 | $4.88 | $40,846 | 237,628 | No | Form 4 |
| Schobel Alexander MarkChief Innovation/Tech Officer | Mar 8, 2024 | Mar 12, 2024 | S | 25,000 | $5.19 | Sale −$129,750 | 1,040,371 | Yes | Form 4 |
| Wargacki StephenSVP, Research & Development | Mar 7, 2024 | Mar 11, 2024 | A | 112,500 | $0.00 | $0 | 270,919 | No | Form 4 |
| Wargacki StephenSVP, Research & Development | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 56,250 | $5.68 | $319,500 | 56,250 | No | Form 4 |
| Boyd Peter E.See Remark | Mar 7, 2024 | Mar 11, 2024 | A | 86,250 | $0.00 | $0 | 245,998 | No | Form 4 |
| Boyd Peter E.See Remark | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 43,125 | $5.68 | $244,950 | 43,125 | No | Form 4 |
| Jung CassieSVP, Operations | Mar 7, 2024 | Mar 11, 2024 | A | 101,250 | $0.00 | $0 | 247,186 | No | Form 4 |
| Jung CassieSVP, Operations | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 50,625 | $5.68 | $287,550 | 50,625 | No | Form 4 |
| Barber DanielPresident and CEO | Mar 7, 2024 | Mar 11, 2024 | A | 242,600 | $0.00 | $0 | 883,302 | No | Form 4 |
| Barber DanielPresident and CEO | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 363,900 | $5.68 | $2,066,952 | 363,900 | No | Form 4 |
| Kraus Carl NChief Medical Officer | Mar 7, 2024 | Mar 11, 2024 | A | 112,500 | $0.00 | $0 | 262,500 | No | Form 4 |
| Kraus Carl NChief Medical Officer | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 56,250 | $5.68 | $319,500 | 56,250 | No | Form 4 |
| Schobel Alexander MarkChief Innovation/Tech Officer | Mar 7, 2024 | Mar 11, 2024 | A | 82,500 | $0.00 | $0 | 1,065,371 | No | Form 4 |
| Schobel Alexander MarkChief Innovation/Tech Officer | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 41,250 | $5.68 | $234,300 | 41,250 | No | Form 4 |
| Toth A Ernest JrSVP, Chief Financial Officer | Mar 7, 2024 | Mar 11, 2024 | A | 120,000 | $0.00 | $0 | 260,000 | No | Form 4 |
| Toth A Ernest JrSVP, Chief Financial Officer | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 60,000 | $5.68 | $340,800 | 60,000 | No | Form 4 |
| Braender Lori JSVP, General Counsel | Mar 7, 2024 | Mar 11, 2024 | A | 135,000 | $0.00 | $0 | 323,761 | No | Form 4 |
| Braender Lori JSVP, General Counsel | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 67,500 | $5.68 | $383,400 | 67,500 | No | Form 4 |
| Wargacki StephenSVP, Research & Development | Mar 10, 2023 | Mar 11, 2024 | F | 1,981 | $0.79 | $1,565 | 158,419 | No | Form 4 |
| Jung CassieSVP, Operations | Mar 10, 2023 | Mar 11, 2024 | F | 1,365 | $0.00 | $0 | 145,936 | No | Form 4 |